J. Jansson

CD23+CD21highCD1dhigh B Cells in Inflamed Lymph Nodes Are a Locally Differentiated Population with Increased Antigen Capture and Activation Potential

E. Schwarz, A. Bottaro, I. Sanz, 2012, The Journal of Immunology.

CD23CD21CD1d B Cells in Inflamed Lymph Nodes Are a Locally Differentiated Population with Increased Antigen Capture and Activation Potential

E. Schwarz, I. Sanz, S. Moshkani, 2012 .

Antigen Capture and Activation Potential Differentiated Population with Increased Inflamed Lymph Nodes Are a Locally B Cells inhighCD 1 dhighCD 21 + CD 23

E. Schwarz, A. Bottaro, I. Sanz, 2012 .

Evidence of B cell immune responses to acute lymphoblastic leukemia in murine allogeneic hematopoietic stem cell transplantation recipients treated with donor lymphocyte infusion and/or vaccination.

C. Mullen, Y. Hsu, Andrew Campbell, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A/ARF mutations retain susceptibility to alloreactive T cells.

C. Jordan, C. Mullen, F. Young, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

P510 Dose escalation of subcutaneous vedolizumab in patients with ulcerative colitis: A post hoc analysis of the VISIBLE trial data

G. D'Haens, D. Wolf, W. Sandborn, 2020 .

A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease

P. Chevallier, I. Yakoub-Agha, M. Mohty, 2021, Bone Marrow Transplantation.

Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Yi-Bin Chen, S. Devine, C. Cutler, 2019, Blood advances.

Differential gene expression in acute lymphoblastic leukemia cells surviving allogeneic transplant

C. Mullen, J. Shand, Y. Hsu, 2010, Cancer Immunology, Immunotherapy.

Acute lymphoblastic leukemia cells that survive combination chemotherapy in vivo remain sensitive to allogeneic immune effects.

C. Mullen, Y. Hsu, I. Kuzin, 2011, Leukemia research.